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Background: Toll-like receptor 4 (TLR4), a lipopolysaccharide (LPS) receptor complex signal-transducing molecule,
plays a crucial role in sensing LPS from gram-negative bacteria. TLR4 signaling pathway activation by LPS plays a
major role in sepsis pathogenesis. A single nucleotide polymorphism, rs11536889, in the 3’-untranslated region of
the TLR4 gene is thought to affect TLR4 translation. This study aimed to investigate whether organ failure in sepsis
patients is related to the TLR4 rs11536889 genotype.
Methods: Adult Caucasian patients with sepsis from the intensive care unit of a university medical center were
followed up for 90 days, and organ failure was recorded as the primary outcome variable. Blood samples were
collected at enrollment for TLR4 rs11536889 genotyping. Sepsis-related organ failure assessment (SOFA) scores were
quantified at sepsis onset and throughout the observational period to monitor organ failure.
Results: A total of 210 critically ill patients with sepsis were enrolled into this study. Wild-type GG was compared to
GC/CC. During their stay in the intensive care unit, GG patients presented significantly higher SOFA scores than did
C allele carriers (7.9 ± 4.5 and 6.8 ± 4.2, respectively; p = 0.0005). Analysis of organ-specific SOFA sub-scores revealed
significant differences in three organ systems: renal, coagulation and hepatic (p = 0.0005, p = 0.0245 and p < 0.0001,
respectively). Additionally, the rs11536889 polymorphism was associated with a higher incidence of gram-negative
infections.
Conclusions: These results offer the first evidence that TLR4 rs11536889 is a useful marker of organ failure in
patients with sepsis.
Keywords: Toll-like receptor 4, Single-nucleotide polymorphism (SNP), Intensive care unit, Organ failure marker,
SOFA scoresBackground
Sepsis is a major health challenge. Despite improved treat-
ment options, sepsis remains a leading cause of death in
intensive care units [1]. Lipopolysaccharide (LPS), or
endotoxin, the major outer membrane component of
gram-negative bacteria, is a potent inflammatory response
stimulator [2]. In addition, LPS triggers inflammation in* Correspondence: ashham.mansur@med.uni-goettingen.de
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unless otherwise stated.gram-negative sepsis [3]. Excessive amounts of gut-
derived LPS released during intestinal hypo-perfusion
have also been implicated in sepsis caused by gram-
positive and fungal infections [4,5]. LPS signaling is initi-
ated by the activation of the myeloid differentiation factor
2 and toll-like receptor 4 (TLR4) complexes on myeloid
cells [2,6]. TLR4 has recently been shown to recognize en-
dogenous danger-type, or ‘alarmin,’ factors, thereby impli-
cating TLR4 as a tissue injury and microbial invasion
sensor [7]. Studies using mouse strains deficient in TLR4
signaling [8,9] or expression [10-13] or those using TLRLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Mansur et al. Journal of Translational Medicine 2014, 12:177 Page 2 of 8
http://www.translational-medicine.com/content/12/1/177inhibitors in wild-type mice [14,15] confirmed that TLR4
contributes to bacterial clearance and the host inflamma-
tory response in the infection setting [16].
Two missense single nucleotide polymorphisms (SNPs) in
the TLR4 gene, Asp299Gly/Thr399Ile, have been reported
to be associated with endotoxin hypo-responsiveness
to inhaled LPS [17]. This investigation was followed
by a series of studies that explored the potential im-
pact of these SNPs on the incidence and course of in-
fectious diseases [18], such as septic shock with gram-
negative bacterial infection [19]. Although some studies
have shown a relevance of the Asp299Gly/Thr399Ile SNPs
in gram-negative infections, others did not confirm
this association [20-22]. Furthermore, recent studies
using primary cells isolated from individuals bearing
these mutations have indicated that the Asp299Gly/
Thr399Ile haplotype has little or no effect on LPS re-
sponsiveness [23].
Recently, Sato et al. demonstrated the biological signifi-
cance of a genetic variation of the TLR4 gene called
rs11536889. Functional analyses revealed that TLR4
rs11536889 contributes to the translational regulation
of TLR4 expression and has some influence on the re-
sponse to LPS, possibly by binding to microRNAs, which
act in post-transcriptional regulation [24]. A large study
that included prostate cancer patients and age-matched
controls from Sweden revealed an association between
TLR4 rs11536889 and prostate cancer [25]. Later, Hishida
et al. observed that TLR4 rs11536889 genotypes are associ-
ated with severe gastric atrophy in helicobacter pylori-sero-
positive Japanese subjects [26]. Zhou et al. found that the
TLR4 rs11536889 SNP is significantly associated with
hepatitis type B virus recurrence after liver transplantation
[27]. In addition, Miedema et al. found that this SNP is as-
sociated with an increased risk of chemotherapy-induced
neutropenia in children with acute lymphoblastic leukemia
[28]. These observations suggest that the rs11536889 gen-
etic variation of the TLR4 gene may influence human in-
flammatory and/or malignant diseases [24].
This study aimed at exploring whether the putative
regulatory TLR4 rs11536889 genotypes relate to organ
failure severity in critically ill patients with sepsis during
their time in the intensive care unit. The outcomes of
wild-type GG were compared to those of GC/CC.
Methods
Patients
Adult Caucasian patients admitted to the University Medical
Center Goettingen (UMG) intensive care units (ICUs)
between April 2012 and May 2013 were screened daily
according to the American College of Chest Physicians/
Society of Critical Care Medicine (ACCP/SCCM) criteria
for sepsis, severe sepsis, or septic shock [29,30]. Caucasian
origin was assessed by questioning the patients, their nextof kin or their legal representatives. The patient exclusion
criteria were as follows: 1. age younger than 18 years; 2.
pregnancy, nursing an infant, or planning to become preg-
nant or nurse an infant; 3. receiving an immunosuppres-
sive therapy (e.g., cyclosporine or azathioprine) or cancer-
related chemotherapy; 4. a documented or suspected
acute myocardial infarction within the previous six weeks;
5. a history of New York Heart Association functional
class IV chronic heart failure: 6. human immunodeficiency
virus infection or end-stage process (e.g., progressive
multifocal leukoencephalopathy or systemic Mycobacter-
ium avium infection); 7. morbidity and death were consid-
ered imminent, the patient was classified as “do not
resuscitate” or “do not treat”, or the patient and/or a le-
gally authorized representative was not committed to ag-
gressive management; 8. the patient was not expected to
survive the observation period of 28 days or was not likely
to be given life support because of a preexisting, uncor-
rectable medical condition, including a poorly controlled
neoplasm, end-stage lung disease, or home oxygen re-
quirement; 9. the patient was in a chronic vegetative state
or had a similar long-term neurologic condition; 10. par-
ticipation in any other investigational study (drug or de-
vice); 11. the patient was unwilling or unable to be fully
evaluated during the study period; and 12. the patient was
a study-site employee or was an immediate family mem-
ber of a study-site employee involved in the study. The
study was approved by the University of Goettingen ethics
committee, Goettingen, Germany (15/1/12) and con-
formed to the Declaration of Helsinki ethical principles
(Seoul, 2008). Written informed consent was obtained ei-
ther from patients or their legal representatives.
Data collection
The Sequential Organ Failure Assessment (SOFA) [31]
and Acute Physiology and Chronic Health Evaluation
(APACHE) II [32] scores were evaluated at the onset of
sepsis. Organ function was assessed subsequently on
days 2, 3, 5, 7, 14, 21 and 28, and organ failure was
quantified, with the SOFA score as the primary outcome
variable. Patients were followed up for a maximum of
90 days, and their deaths were recorded as a secondary
outcome variable. The necessity of mechanical ventila-
tion, vasopressor administration, or renal-replacement
therapy as well as the ICU duration was recorded as sec-
ondary variables.
TLR4 rs11536889 genotyping
Peripheral blood monocytes (PBMCs) from approxi-
mately 30 ml of heparinized peripheral blood were iso-
lated through Ficoll density gradient centrifugation
according to standard procedures described previously
[33]. Cell preparations were routinely assessed for viabil-
ity (>95%) by trypan blue dye exclusion.
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the AllPrep DNA Mini Kit (Qiagen, Hilden, Germany) ac-
cording to the manufacturer’s protocol. The isolated nu-
cleic acid concentration and purity were determined by
260 and 280 nm optical density readings. DNA integrity
was evaluated through 0.6% agarose gel electrophoresis.
Genotyping was performed using 4 ng of PBMC-derived
gDNA in a commercially available genotyping assay (Assay
ID C_31784034_10, Applied Biosystems, Darmstadt,
Germany) in a total volume of 10 μl. The reactions were
performed in a StepOnePlus sequence detection system
(Applied Biosystems, Darmstadt, Germany) according
to the supplier’s instructions.
Statistical analyses
The Hardy-Weinberg equilibrium exact test for deviation
was performed using an online calculator, which was
provided by the Institute of Human Genetics, Helmholtz
Center Munich, Germany (http://ihg.gsf.de/cgi-bin/hw/
hwa1.pl). Statistical analyses were performed with the
Statistica (StatSoft, Tulsa, Oklahoma, USA, version 10) or R
(The R Foundation for Statistical Computing, version 3.0.0)
software. Significance, based on contingency tables, was
calculated using two-sided Fisher’s exact or chi-square tests,
as appropriate. Two continuous variables were compared
using the Mann-Whitney test. To estimate the significance
of the clinical observations over the 28-day period, we fitted
a linear regression model with the parameters day, geno-
type, and genotype-day interaction. The results were visual-
ized by calculating the means and 95% confidence intervals
(CIs) from normal distributions at each time point. Time-
to-event data were compared using the log-rank test from




A total of 212 adult Caucasian patients with sepsis were
enrolled into this study. Two patients were excluded; one
patient fulfilled an exclusion criterion, as a B cell lymph-
oma diagnosis became known, and the other patient was
excluded because informed consent was withdrawn by his
legally authorized representative. Subsequently, the study
population comprised 210 patients, in which 134 were
male (64%), and 76 were female (36%; Table 1). The pa-
tient ages ranged from 19 to 91 (median, 65). The sepsis
subtypes were sepsis/severe sepsis (n = 100) and septic
shock (n = 110). At baseline, the patient disease severity
SOFA and APACHE II scores were 8.6 ± 4.1 and 21.3 ±
7.4, respectively (Table 1). The comorbidities comprised
hypertension, myocardial infarction history, chronic ob-
structive pulmonary disease (COPD), renal dysfunction,
diabetes mellitus, chronic liver diseases, cancer history,
and stroke history (Table 1).Disease severity at sepsis onset
TLR4 rs11536889 was successfully genotyped in all sub-
jects. The genotype distribution was 146:62:2 (GG:GC:
CC), which was consistent with the Hardy-Weinberg
equilibrium (p = 0.12). The resulting 0.16 minor allele
frequency was similar to that given for Caucasians in
public databases. The rs11536889 GC and CC genotypes
were pooled together because the size of the CC geno-
type group was too small (n = 2). Subsequently, patients
of genotype GG were compared to that of CG/CC.
There was no difference regarding age, gender, or body
mass index related to the TLR4 rs11536889 genotype. A
comparison between the G homozygous patients and C
allele carriers revealed no significant difference between
the proportion of patients with sepsis/severe sepsis and
septic shock at baseline (day 1 of sepsis; p = 0.4576). Fur-
thermore, there were no SOFA and APACHE II score
differences regarding the TLR4 rs11536889 genotypes at
sepsis onset, and there were no significant preexisting
conditions differences between the TLR4 rs11536889 ge-
notypes (Table 1). Moreover, the recent surgical histories
and primary infection sites showed no significant differ-
ence with respect to the genotype distribution (Table 1).
Disease progression and mortality
Disease progression was monitored by SOFA score
changes during the patient ICU stays. The scores and the
need for organ support were recorded on days 1, 2, 3, 5, 7,
14, 21, and 28. Although no differences in disease scores
were observed at sepsis onset, the TLR4 rs11536889 GG
patients experienced significantly higher SOFA scores over
time (p = 0.0005) compared with the C allele carriers
(Table 2). The three organ-specific SOFA scores were sig-
nificantly different between the two groups; the GG pa-
tients presented higher SOFA-renal scores (p = 0.0005),
SOFA-coagulation scores (p = 0.0245), and SOFA-hepatic
scores (p < 0.0001; Table 2, Figure 1). An overall linear
model was fitted to the values, which included the various
time points. This model also revealed a significant geno-
type effect; the GG patients presented higher SOFA scores
than did the GC/CC subjects (p = 0.015; Figure 2). The
mean SOFA scores of the two CC patients were 11.6 ± 3.5
(mean ± SD). Among all SOFA scores, the minimum and
maximum were 0 and 23, respectively.
The 28-day and 90-day mortality analyses yielded
no significant result between the groups (p = 1.0000
and p = 0.8698, respectively; Table 2 (Additional file 1:
Figure S1)). Both at the beginning and over the observa-
tional period, there was no significant difference between
the GG patients and C allele carriers regarding organ sup-
port requirement (mechanical ventilation, vasopressor
use, and renal replacement therapy; Tables 1 and 2). The
mean ICU stay duration of the GG survivors did not differ
significantly from that of the GC/CC survivors (Table 2).
Table 1 Patient baseline characteristics with regard to the TLR4 rs11536889 genotypes
All n = 210 GG n = 146 GC/CC n = 64 p value
Age [years] 63 ± 15 63 ± 16 63 ± 15 0.9116
Male, % 64% 46% 58% 0.2752
Body-mass index, mean ± SD 28 ± 9 28 ± 7 30 ± 13 0.1507
Severity of sepsis 48% 46% 52% 0.4576
Sepsis/severe sepsis, % 52% 54% 48%
Septic shock, %
SOFA score, mean ± SD 8.6 ± 4.1 8.9 ± 4.3 8.0 ± 3.7 0.2449
APACHE II score, mean ± SD 21.3 ± 7.4 21.6 ± 7.4 20.6 ± 7.6 0.4053
Comorbidities, %
Hypertension 58 59 1.0000
History of myocardial infarction 5 6 0.7586
COPD 18 17 1.0000
Renal dysfunction 11 20 0.0834
Diabetes mellitus (NIDDM) 11 8 0.6202
Diabetes mellitus (IDDM) 11 5 0.1938
Chronic liver diseases 7 9 0.7839
History of cancer 18 19 0.8481
History of stroke 6 8 0.7647
Recent surgical history, % 0.0631
Elective surgery 28 31 19
Emergency surgery 44 44 44
No history of surgery 28 24 37
Site of infection, % 0.1516
Lung 50 46 56
Abdomen 30 31 28
Bone or soft tissue 7 7 6
Surgical wound 2 3 0
Urogenital 1 0 3
Primary bacteremia 6 7 3
Other 4 5 3
Organ support, %
Mechanical ventilation 83 83 83 0.8933
Use of vasopressor 52 54 48 0.4576
Renal-replacement therapy 10 11 9 0.7300
The data are presented as the mean ± SD or percentages.
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negative infection incidence rate among the C allele car-
riers (81%) compared with that in the GG patients (62%;
p = 0.0062) (Table 3).
Discussion
The present study addressed the question of whether the
putative regulatory TLR4 rs11536889 genotypes are re-
lated to organ failure in critically ill patients with sepsis.The primary endpoint, organ failure, was quantified
using SOFA scores as a specific clinical marker in pa-
tients with sepsis and was significantly higher in TLR4
rs11536889 GG patients compared with those of TLR4
rs11536889 GC and CC patients (Table 2).
The TLR4 rs11536889 genotype distribution among
the septic patients was similar to database entries re-
garding healthy Caucasians and also followed the Hardy-
Weinberg equilibrium. The TLR4 rs11536889 genotypes,
Table 2 Disease progression with regard to the TLR4 rs11536889 genotypes
All n = 210 GG n = 146 GC/CC n = 64 p value
SOFA 7.6 ± 4.5 7.9 ± 4.5 6.8 ± 4.2 0.0005
SOFA-Respiratory score 2.1 ± 1.1 2.1 ± 1.1 2.0 ± 1.1 0.1950
SOFA-Cardiovascular score 1.6 ± 1.5 1.7 ± 1.5 1.4 ± 1.4 0.1296
SOFA-Central nervous system score 2.0 ± 1.5 2.1 ± 1.5 1.9 ± 1.4 0.0802
SOFA-Renal score 0.9 ± 1.4 1.0 ± 1.4 0.7 ± 1.2 0.0005
SOFA-Coagulation score 0.3 ± 0.8 0.4 ± 0.8 0.3 ± 0.7 0.0245
SOFA-Hepatic score 0.3 ± 0.7 0.4 ± 0.8 0.2 ± 0.5 <0.0001
Mortality analysis, %:
Death at day 28 18 18 17 1.0000
Death at day 90 30 30 28 0.8698
Length of stay in ICU (days) 18 ± 16 18 ± 17 20 ± 14 0.0720
Organ support*, %
Mechanical ventilation 75 74 0.6286
Use of vasopressor 38 37 0.8426
Renal replacement therapy 14 9 0.4486
The data are presented as the mean ± SD or percentages.
*Based on the total number of observations in follow-up days.
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baseline characteristics. As assessed by scoring the sepsis
type (sepsis and severe sepsis vs. septic shock) and SOFA
and APACHE II scores, we found that the TLR4
rs11536889 genotypes were also not related to the septic
disease severity at sepsis onset (Table 1). We believe that
the SOFA scores at sepsis onset did not differ between
the GG versus GC and CC genotypes because of the
phenotypic heterogeneity of the sepsis syndrome. This
heterogeneity is influenced by many factors, including
the pathogenic organism responsible for the infection,
its location, and the amount of time passed since the on-
set of infection, as well as other individual parameters.
To detect genotypic differences, a longitudinal observa-
tion involving SOFA scores quantified over the study
period is much more promising (Table 2).
As shown by Sato et al., monocytes from TLR4 rs11536889
CC subjects expressed significantly higher levels of TLR4
compared with those from TLR4 rs11536889 GG and GC
subjects. When PBMCs were stimulated with LPS, a TLR4
ligand, the cells from the TLR4 rs11536889 CC and GC
subjects secreted significantly higher levels of the proin-
flammatory cytokine IL-8 compared to cells from the GG
subjects [24]. Accordingly, these previous investigations
support the assumption that TLR4 rs11536889 GG sepsis
patients present severe organ dysfunction (as measured
using SOFA scores) because of attenuated TLR4 proin-
flammatory signaling in response to LPS compared to C
allele carriers.
These significant results, with respect to organ dysfunc-
tion, reveal severe morbidity among TLR4 rs11536889 GGpatients (according to SOFA scores) and together with the
fact that GG patients are assumed to present attenuated
TLR4 expression [24], offer an explanation why synthetic
TLR4 antagonists have failed to produce a clinical benefit
in patients with severe sepsis [14,15]. These agents may
alter the inflammatory response via TLR4 to pathogens,
thereby contributing to organ dysfunction in these patients.
The SOFA-renal score was higher in TLR4 rs11536889
GG patients, indicating severe renal dysfunction in this
group. Because TLR4 rs11536889 GG patients may ex-
hibit decreased TLR4 expression, our results are consist-
ent with former observations indicating that decreased
TLR4 expression in chronic kidney disease patients was
associated with attenuated proinflammatory cytokine
synthesis during infection [34]. The observed severe
hepatic dysfunction measured using the SOFA-hepatic
score among TLR4 rs11536889 GG subjects, indicating
severe hyperbilirubinemia in this group, is in agreement
with recent findings reported by Deng et al. [16] that
TLR4 signaling is essential for LPS clearance by hepato-
cytes during sepsis. The absence of an association
between the rs11536889 genotypes and the SOFA re-
spiratory score may be attributed to the fact that the
SOFA respiratory score is somewhat weak because it
only refers to the oxygenation index. This score depends
on several factors, such as ventilator settings during
mechanical ventilation and different ventilator settings
that result in different oxygenation indices, which lead
to score variation. We believe that there was no signifi-
cant difference in the SOFA-CNS score between the ge-







































































































































Figure 1 SOFA sub-scores by genotype on each day during the follow-up period. The means are indicated by horizontal bars. The boxes
are limited by the 25th and 75th percentile. The whiskers represent the minimum and maximum. The differences were not significant except
where indicated by*.
Figure 2 SOFA score by genotype during the follow-up period. The means and 95% normal CIs plus regression lines are displayed. The box
displays the coefficients and P values from a linear regression model that models the SOFA scores as a function of the follow-up day
and genotype.
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Table 3 Infection types over the observational period
GG n = 146 GC/CC n = 64 p value
Infection type
Gram-negative 62% 81% 0.0062
Gram-positive 83% 83% 1.0000
Fungal 52% 58% 0.4565
Viral 18% 17% 1.0000
Parasitic 0% 0%
Other 1% 3%
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affects the SOFA-CNS score. The SOFA-Cardiovascular
score most likely did not differ between GG patients and
C allele carriers because this score is only based on the
catecholamine therapy needed, which depends on volu-
metric status and cardiac function.
Analysis of the 28-day and 90-day mortality revealed no
significant differences among the TLR4 rs11536889 geno-
types. The severe organ failure observed in G homozygous
patients may not have contributed to higher mortality
rates because the patients received sufficient intensive care
treatment, which allowed their organ failures to be man-
aged appropriately. The patients were treated according to
current guidelines for the treatment of sepsis (Surviving
Sepsis Campaign) [35].
Additionally, there was a significantly higher gram-
negative infection rate among the C allele carriers
(81%) compared with the rate observed in the GG pa-
tients (62%; p = 0.0062) (Table 3). This result is in
agreement with previous observations linking this poly-
morphism with an increased susceptibility to infection
[24,26,27]. This observation of higher susceptibility of
C allele carriers to gram-negative infections should be
thoroughly examined in future studies to detect any
causality between the SNP and susceptibility to gram-
negative infections.
A possible limitation of this study is the possibility
that the studied TLR4 rs11536889 SNP associated with
organ failure in patients with sepsis is in linkage dis-
equilibrium with SNPs in another nearby gene and that
these latter genes are responsible for the observed
phenotypic effects.
To the best of our knowledge, this is the first investi-
gation evaluating this putative regulatory polymorphism
in this key innate immune receptor in adult Caucasian
sepsis patients, showing a significant association between
the TLR4 rs11536889 GG genotype and the severity of
organ failure (renal, coagulation and hepatic). According
to these results, it would be worthwhile to further assess
the TLR4 rs11536889 polymorphism for its relevance to
sepsis in larger and independent cohorts.Conclusions
This study assesses the validity of the assumption that a
well-known regulatory TLR4 polymorphism influences
the outcome of sepsis among adults. An analysis of
organ-specific SOFA sub-scores revealed significant dif-
ferences in three organ systems: renal, coagulation and
hepatic. These results offer the first evidence that TLR4
rs11536889 is a useful marker of organ failure in patients
with sepsis. This polymorphism should be assessed for
its organ failure relevance in sepsis in larger, independ-
ent cohorts.
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Additional file 1: Kaplan-Meier survival analysis. The Kaplan-Meier
curve shows the survival curves censored at day 90 for the TLR4 rs11536889
GG and GC/CC genotypes. A mortality risk among the patients under study
did not differ between the two groups.
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